#32 - Identifying Subgroups of Intersectional Stigma, Discrimination, and the Association With Mental Health Outcomes Among HIV-Positive MSM: Latent Class Analysis

Liying Wang, United States

#37 - HIV Provider Framings of Caring for Patients Aging with HIV

Abigail Baim-Lance, United States

#50 - Maltreatment, Abuse, and Neglect among Sexual and Gender Minorities and People Living with HIV: A Mixed-Method Examination of Correlates and Improved Screening

Casey Xavier Hall, United States

#53 - Psychological Resilience Protects Against Cortical Thinning in the Default Mode Network in Older Adults Living With HIV

Amy Ankoh, United States

Guided Poster Tour 3: Treatment and Medications

Moderators

Savita Pawha & Joe Margolick

#29 - Comparative Effects of Efavirenz and Dolutegravir on Metabolomic Profiles, Cytokines and Platelet Activation of People Living with HIV

Crystal Roux, South Africa

#35 - Clinical and Pharmacological Outcomes of Real-World Use of Long-Acting Cabotegravir and Rilpivirine in France; Efficacy and Tolerance during the First 72 Weeks

Christina K. Psomas, France

#48 - Switching to a Fixed-Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed, Treatment-Experienced People with HIV (PWH) ≥ 65 Years Old

Tulika Singh, United States

#49 - Low Bone Mineral Density in People Living With HIV and Its Correlation With Bone Health Quality of Life - Observational Study Conducted by Treatment Adherence Advocacy and Literacy - TAAL+ Integrated Health Center and Community Pharmacy - A Peer Led

Manojkumar Pardeshi, India

Guided Poster Tour 4: Community and Well-Being

Moderator

Eugenia Siegler & Simon Collins

#36 - “I’m 62-Years-Old and I Still Have Sex. It’s Not All the Time, but It’s When I Want It!” Sexual Health, Wellness, and Aging With HIV: In Our Own Words

Megan Ebor, United States

#42 - Menopause and You: A Knowledge Translation Project for Women Living with HIV Exploring Menopause

Leanne Flinton, Canada

#45 - Utilization of Medical Case Manager Assessment for Older Adults with HIV and Long-Term Survivors of HIV to Enhance Quality of Life and Well-Being

Claudia Mccann, United States

#52 - Using Participatory Approaches and Conceptual Analysis for the Development of a Community-Based Tablet/Hotspot Lending Program for Older Adults Living with HIV

Haley Sanner, United States

Guided Poster Tour 5: International

Moderators

Julian Falutz & Scott Letendre

#57 - Forecasting the Effect of HIV-Targeted Interventions on the Age Distribution of People Living With HIV: A Case Study From Kenya

Melissa Schnure, United States

#58 - Age and Sex-Based Discordance of Anthropometric Measures and Association With Metabolic Risk Factors Among Ugandans Living With HIV

Redeat Assefa, United States

Guided Poster Tour 6: Physical & Cognitive Function

Moderators

Bruce Brew & Marie-Josée Brouillette

#21 - Frailty and the Area Deprivation Index as Indicator of Neighborhood Disadvantage among Older People with HIV in Colorado

Grace L. Ditzenberger, United States

#30 - Relationships Between Plasma Neurofilament Light Chain Protein, Cognition, and Brain Aging in People With HIV

Sarah Cooley, United States

#31 - Using Network Analysis to Provide Evidence for Brain Health as a Unified Construct Relevant to Aging With HIV

Mohamad Matout, Canada

#56 - Hepcidin Modifies the Relationship Between Age, Erythrocyte Indices, and Neurocognitive (NC) Performance in Virally Suppressed People With HIV (PWH)

Azin Tavasoli, United States

Friday 27 October

Mentoring Session -

Focus on Global Mentorship

Charles Flexner, MD

Johns Hopkins University School of Medicine, United States

Video

Session 6: Risk Index for Vascular Complications in the Elderly -

Multifactorial Risk Factors for Cognitive Impairment

Scott Letendre, MD

University of California – San Diego, United States

Video

Slideset

#17 - Cardiometabolic Disease Among Frailty Phenotype Clusters in Adults Aging with HIV

Ray Jones

United States

Video

Slideset

#18 - Plasma Proteomic Signatures Capture Unique Cardiovascular Risk Phenotypes Among Persons Living With and Without HIV in the United States

Tess Peterson

United States

Video

Slideset

#19 - Inverse Balance in Plasma Levels of the Endocannabinoids N-arachidonoylethanolamine and 2-arachidonoylglycerol and their Congeners in People with HIV with Subclinical Coronary Artery Disease: Results from the Canadian HIV and Aging Cohort Study.

Cecilia Costiniuk

United States

Video

Slideset

Session 7: ARV Management of the Aging Patient -

Age-related Changes in the PK of Long-Acting Drugs in the Elderly

Charles Flexner, MD

Johns Hopkins University School of Medicine, United States

Video

Slideset

Industry-Supported Symposium: Asymptomatic Neurocognitive Impairment in People Living With HIV - Impact of (Not) Knowing -

Chair

Underlying Mechanisms of Asymptomatic Neurocognitive Impairment

April D. Thames, PhD

University of California, Los Angeles, Unites States

Debate: Screening for ANI is Beneficial for PLWH and Should be Recommended

David Moore, PhD

University of California – San Diego, United States

Alan Winston, MBChB, FRCP, MD

Imperial College, United Kingdom

A Community Perspective on the Screening of ANI

Andy Kaytes

University of California - San Diego, United States

Session 8: How Do We Make This Happen / Prevent Complications -

Resilience in Older Patients (With and Without HIV)

Michael Plankey, PhD

Georgetown University Medical Center, United States

Community Forum: Challenges and Proposed Solutions

Jules Levin, MS

National AIDS Treatment Advocacy Project, United States

Jen Lothridge

Christie’s Place, United States

Marlene Matosky, MPH, RN

Health Resources and Services Administration HIV/AIDS Bureau, United States

Linda H. Scruggs DHL, MHS

Ribbon, United States

Video

Special Session: DC Community Conversation on Aging and HIV

Video

General

Welcome

The 14th International Workshop on HIV & Aging took place in a hybrid format from 26-27 October 2023, in Washington DC, United States.

The next edition of the International Workshop on HIV & Aging will take place in Washington DC, on 24-25 October 2024.

The integration of antiretroviral therapy (ART) into HIV care has dramatically extended the life expectancy of those living with HIV. This increased life expectancy is changing the demographics of the HIV epidemic. Currently, over half of individuals living with HIV are aged 50 or older. Recent estimates in Europe suggest that more than 70% of those with HIV will be over the age of 50 by 2030, accompanied by a greater burden of comorbidities and the associated treatments. In comparison to similar populations, persons with HIV, even when on effective ART, experience an excess of morbidity and mortality. Complications due to AIDS are rarely fatal for persons on ART. Instead, patients experience an early onset of aging complications, including neurocognitive decline, osteoporosis and fractures, impaired physical function, frailty, and falls.

Improving the management of older adults with HIV will require a much deeper understanding of the interface between aging, HIV, associated comorbid conditions, and concurrent treatment. Additionally, research is needed to address the unique psychosocial challenges faced by this growing population. The elderly population living with HIV is particularly vulnerable to social stigma, which can lead to depression, psychological distress, compromised adherence to therapy, and overall poor treatment outcomes and quality of life.

The International Workshop on HIV and Aging remains the only platform worldwide for international, cross-disciplinary scientific exchange on the increasingly recognized difficulties encountered in the clinical care and design of studies to improve the care of persons aging with HIV. The meeting gathers (basic) researchers, healthcare professionals across different disciplines, and community advocates to foster dialogue and prompt solutions that will benefit the aging population living with HIV. In addition, the workshop will also create opportunities for trainees and junior investigators to present their research, network, and learn from experts in the field.

Chairs

Kristine Erlandson, MD, MS

University of Colorado Denver- Anschutz Medical Campus, United States

Joseph Margolick, MD, PhD

Johns Hopkins Bloomberg School of Public Health, United States

David Moore, PhD

University of California – San Diego, United States

General Information

Uniques Features

• Invited lectures from international experts
• Interactive roundtable discussions
• Ample time for discussion

Who Should Attend?

Internal Medicine specialists (clinicians working in cardiovascular, renal, endocrine, and metabolic complications of HIV areas), infectious disease specialists, (virologists, immunologists, pharmacologists), geriatricians, neurologists, epidemiologists, geneticists and other clinical researchers; community advocates, industry representatives.

Meeting Objectives

Aim of this meeting is to:

- Facilitate an unbiased and scientific knowledge exchange regarding HIV and ageing and encouraging early career investigators to actively take part in the workshop.

- Inform on the current advances in basic and clinical research in HIV and ageing and promote its successful translation to clinical care options.

- Create awareness on challenges regarding the management of older people living with HIV and catalyze research to combat these challenges

Learning Objectives

After attending this workshop, participants will be able to:

- Outline the underlying mechanisms of sarcopenia in older HIV patients.

- Summarize options to manage sarcopenia in ageing people living with HIV

- Describe the role of nutrient metabolism in older HIV patients

- Describe ways to support mental health in ageing people living with HIV

- Outline complications in older HIV patients

- Explain/Reflect on options to manage complications in ageing people living with HIV

Practical Information

Venue

HIV & Aging 2023 will take place at the Johns Hopkins University.

Full Address:

555 Pennsylvania Avenue NW
Washington, DC, 20001
United States

Distance from Dulles International Airport : 27.2 miles

Accommodation

More information on accommodation can be found on the accommodation tab of the website.

Badges

All participants are requested to wear the badge at all times during the workshop to ensure admission to the meeting.

Certificate of Attendance

A certificate of attendance will be sent to you after successfully completing the program and post-meeting survey.

Language

The official language of the workshop is English. Translation will not be provided.

Enduring Materials

Enduring materials will be available shortly after the conclusion of the workshop.

Disclaimer

This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop.

Liability and Insurance

By registering for the workshop, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.

Photographs, Audio, and Video Recording

Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.

Code of Conduct

All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.

Registration

Please note that payment by credit card is required to be able to register for the workshop. Please contact the conference secretariat if this is not possible for you.

Fees and Conditions

Live Participation

	Regular Delegates	Industry*
Early Fee (payment before/ on 26 July 2023)	$475.00	$1675.00
Standard Fee (payment before/ on 22 October 2023)	$955.00	$2155.00
Onsite Fee / Post-Meeting Fee (payment from 23 October 2023)	$1195.00	$2395.00

Virtual Participation

	Regular Delegates	Industry*
Early Fee (payment before/ on 26 July 2023)	$237.50	$1675.00
Standard Fee (payment before/ on 22 October 2023)	$477.50	$2155.00
Onsite Fee / Post-Meeting Fee (payment from 23 October 2023)	$597.50	$2395.00

Discounts
Early-Career Investigators / Academia from Resource-Limited Settings (RLS)* WITH accepted abstract	100% Discount
Early-Career Investigators / Academia from Resource-Limited Settings (RLS)* WITHOUT accepted abstract	50% Off Current Academia Fee
NGO Representatives / Government Representatives (i.e. MOH, NIH, NIAID, etc.) / Advocates	50% Off Current Academia Fee
Members of Endorsers	25% Off Current Academia Fee
Sponsors	Contact Secretariat
People Living with HIV	100% Discount

*Countries included in the low-income and middle-income economies list of the World Bank Classification

Important

We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.

Registration Fee Includes

- Access to all sessions during the event; and
- All presentation materials as well as recordings 3 weeks after the event.

Group Registration

For registration of groups larger than 5 participants, please use the Group Registration Portal.

Early-Career Investigators / Academia from Resource-limited Settings (RLS)

We are pleased to offer complimentary registration to early-career investigators and academia from low-income and lower-middle-income countries with an accepted abstract and a 50% discount on the registration fee without an accepted abstract.

IMPORTANT: Complimentary registration is offered to the presenting author only.

To be eligible as an early-career investigator, one should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.

Payment

By credit card only: online or by written authorization (see online registration).

Cancellation Policy

In case of cancellation, the following refunds are applicable:

- Cancellation before/on 26 September 2023: 50% refund (minus an administration fee of $40)

- Cancellation after 26 September 2023: Unfortunately, no refund will be given

If you are unable to attend the workshop, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the workshop secretariat has been notified of the name of the substitute delegate before 12 October 2023. A statement (email/letter) of cancellation must be sent to Virology Education.

Liability and Insurance

By registering for the workshop, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.

Media Registration

In order to register as a media participant for the workshop, the workshop secretariat needs to receive:

1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop

A complimentary or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the workshop secretariat for registration conditions.

We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.

Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2023 embargo policy.

Disclaimer

This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop. In case of cancellation of the meeting due to unforeseen circumstances, Virology Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.

Committees

The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.

Organizing Committee

Kristine Erlandson, MD, MS

University of Colorado Denver- Anschutz Medical Campus, United States

Julian Falutz, MD, FRCPC

McGill University, Canada

Meredith Greene, MD

Indiana University School of Medicine, United States

Scott Letendre, MD

University of California – San Diego, United States

Jules Levin, MS

National AIDS Treatment Advocacy Project, United States

Joseph Margolick, MD, PhD

Johns Hopkins Bloomberg School of Public Health, United States

David Moore, PhD

University of California – San Diego, United States

Savita Pahwa, MD

University of Miami School of Medicine, United States

Jonathan Schapiro, MD

National Hemophilia Center, Sheba Medical Center, Israel

Madhav Thambisetty, MD

National Institutes of Health (NIH/NIA), United States

Scientific Committee

The members of Scientific Committee are hand-picked by the Organizing Committee (OC) and the conference secretariat based on their significant contributions and commitment to the field. They assist the OC by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

Dorcas Baker, RN, BSN, ACRN, MA, Johns Hopkins University School of Nursing, MidAtlantic AIDS Education and Training Center (AETC), United States
Bruce Brew, MD, St Vincent's Hospital, Australia
Marie-Josée Brouillette, MD, McGill University Health Centre, Canada
Simon Collins, HIV i-Base, United Kingdom
Daniel Duprez, MD, University of Minnesota (Cardiology), United States
Giovanni Guaraldi, MD, Policlinico Modena, Italy
Jordan Lake, MD, MSc, UTHealth, United States
Alan Landay, PhD, Rush University Medical Center, United States
Catia Marzolini, PharmD, PhD, University Hospital Basel, Switzerland
Eugènia Negredo, MD, PhD, Universitat Autònoma de Barcelona , Spain
Kelly O'Brien, PhD, BScPT, BSc, University of Toronto, Department of Physical Therapy, Canada
Brendan Payne, PhD, Newcastle University, United Kingdom
Molly Perkins, PhD, Emory University School of Medicine, United States
Matilde Sanchez Conde, MD, PhD, Hospital Ramón y Cajal, Spain
Eugenia Siegler, MD, Weill Cornell Medicine, United States
Jeff Taylor, HIV + Aging Research Project - Palm Springs, United States
Phyllis Tien, MD, MSc, University of California - San Francisco, United States
Cara Wilson, MD, University of Colorado, United States

Industry LIaison Board

The Industry Liaison Board, consisting of leading medical scientists of the pharmaceutical industry, is asked to give input and suggestions that help the Organizing Committee in planning the workshop and providing support on topics of interest and innovative suggestions to optimize audience participation. The Industry Liaison Board assists the Organizing Committee by suggesting the most current and critical topics to bring the audience up-to-date on the most current research in the pharmaceutical industry in related disciplines.

Andrew Clark, MD, ViiV Healthcare, United Kingdom
Richard Haubrich, MD, Gilead Sciences, United States
Christian Marsolais, PhD, Theratechnologies, Canada

Endorsers

HIV & Aging 2023 is endorsed by societies and organizations. Their support and collaboration are key to the success of this workshop!

A 25% discount on the academia registration fee is offered to members/employees of endorsers. Please reach out to your organization to obtain the applicable discount code.

If you would like your organization to endorse this workshop, please contact Christina Moustakaki at Christina.Moustakaki @amededu.com

Support

Platinum Level

Silver Level

Symposium Sponsor

Principal Supporter

Supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP

__________________________________________________________________________

Friend Support

Support Our Initiative

Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in International Workshop on HIV & Aging 2023.

This collaboration plays a vital role in both the organizational as well as scientific success of the program.

To show your commitment to the cause, get in touch with us for a tailored
support package by contacting Ms. Lara da Silva Miguel at Lara@amededu.com.

Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

Symposium opportunities
Non-commercial interviews with company representatives
Verbal acknowledgement during the program
Discounted and complimentary registrations for your representatives
Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
Company acknowledgement on printed meeting materials including but not limited to banners and the program book
Digital and printed advertising opportunities
Social media shout-outs
Logo on the conference bag

*Subject to the support level.

Downloads:

SupportLetter_HIV&Aging2023.pdf

Accommodation

We look forward to welcoming you to Washington DC!

As you plan your trip to Washington DC, we want to make your stay as comfortable and convenient as possible. Therefore, we are pleased to offer to all participants of HIV & Aging 2023 some accommodation options near the workshop venue.

To benefit from a special discount on the best available rates, please book your accommodation through the following links.

Booking Links